11	48	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 11), 'text':'FcepsilonRI evoked allergic responses are initiated by mast cells through releasing granules'}, {'start':(0, 12), 'end':(0, 29), 'text':'containing histamine , beta-hexosaminidase , and mast cell specific proteases and by secreting inflammatory cytokines ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 27), 'text':'As a member of the immune receptor superfamily , the FcepsilonRI is composed of IgE binding alpha subunit and signal transducing beta and gamma subunits ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 1), 'text':'Upon cross'}, {'start':(2, 2), 'end':(2, 6), 'text':'linking of the FcepsilonRI ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 7), 'end':(2, 15), 'text':'the Src family protein tyrosine kinase Lyn is activated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 16), 'end':(2, 33), 'text':'and phosphorylates the immunoreceptor tyrosine based activation motifs in the cytoplasmic domains of the beta and gamma subunits'}, {'start':(2, 34), 'end':(2, 39), 'text':'leading to recruitment of Syk .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 26), 'text':'Syk is then activated and further phosphorylates linker for activation of T cells ( LAT ) , SLP-76 , and several other signaling molecules ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 9), 'text':'Upon phosphorylation , LAT assembles a complex of signaling proteins'}, {'start':(4, 10), 'end':(4, 26), 'text':'containing Grb2 , Gads , SLP-76 , and phospholipase C ( PLC ) gamma1 and gamma2 .'}]}, {'start':(5, 0), 'end':(5, 20), 'text':'Recruitment of Sos to LAT by Grb2 likely leads to activation of the Ras-mitogen-activated protein kinase ( MAPK ) pathway .'}]}]}]}]}]}, {'start':(6, 0), 'end':(6, 11), 'text':'Binding of PLCgamma to LAT is necessary for activation of PLCgamma .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 12), 'text':'PLCgamma catalyzes the generation of inositol 1,4,5-triphosphate and diacylglycerol ( DAG ) ,'}, {'start':(7, 13), 'end':(7, 30), 'text':'which are responsible for inducing calcium influx and protein kinase C ( PKC ) activation , respectively .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 14), 'text':'In the absence of LAT , signaling pathways downstream of the FcepsilonRI are impaired .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 16), 'text':'The phosphorylation of SLP-76 and PLCgamma1 and gamma2 as well as calcium flux are significantly reduced .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 19), 'text':'Consequently , mast cell degranulation and cytokine production are severely affected in LAT -/ - mast cells ( ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 13), 'text':'After FcepsilonRI aggregation , another Src family kinase , Fyn , is also activated'}, {'start':(11, 14), 'end':(11, 17), 'text':'and phosphorylates Gab2 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 16), 'text':'After phosphorylation , Gab2 binds the p85 subunit of phosphatidyl inositol 3 kinase ( PI3K ) .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 4), 'text':'Studies using Gab2 -/ -'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 5), 'end':(13, 7), 'text':'mast cells show'}, {'start':(13, 8), 'end':(13, 15), 'text':'that Gab2 is essential for PI3K activation .'}]}]}, {'start':(14, 0), 'end':(14, 18), 'text':'However , it is not clear how PI3K is activated after recruitment to the plasma membrane by Gab2 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 2), 'text':'Previous data show'}, {'start':(15, 3), 'end':(15, 30), 'text':'that in platelet derived growth factor receptor mediated signaling , GTP bound Ras is capable of activating PI3K by binding to the p110 catalytic subunit ( ) .'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 8), 'text':'After PI3K activation , phosphatidyl inositol-3 ,4,5 - triphosphate'}, {'start':(16, 9), 'end':(16, 24), 'text':'( PIP 3 ) - dependent kinase 1 ( PDK1 ) is relocated to the membrane'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 25), 'end':(16, 29), 'text':'by binding to PIP 3'}, {'start':(16, 30), 'end':(16, 37), 'text':'and activated through intermolecular auto-phosphorylation ( ) .'}]}]}]}]}, {'start':(17, 0), 'end':(17, 8), 'text':'PDK1 then phosphorylates and activates Akt and PKCdelta .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 12), 'text':'Fyn deficient mast cells have impaired PI3K activation and degranulation ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 13), 'end':(18, 13), 'text':'indicating'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 14), 'end':(18, 17), 'text':'that the Fyn initiated'}, {'start':(18, 18), 'end':(18, 25), 'text':'pathway is important in mast cell degranulation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 2), 'text':'Recent studies show'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 3), 'end':(19, 6), 'text':'that cytoskeleton rearrangement ,'}, {'start':(19, 7), 'end':(19, 14), 'text':'which is regulated by the PI3K pathway ,'}]}, {'start':(19, 15), 'end':(19, 27), 'text':'is required for granule translocation and mast cell degranulation ( - ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 3), 'text':'It has been suggested'}, {'start':(20, 4), 'end':(20, 10), 'text':'that degranulation is a two-step process :'}]}, {'start':(20, 11), 'end':(20, 21), 'text':'granule translocation to the plasma membrane and granule-plasma membrane fusion .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 13), 'text':'Although granule translocation requires Fyn and Gab2 , RhoA , and microtubule formation ,'}, {'start':(21, 14), 'end':(21, 22), 'text':'granule-plasma membrane fusion is calcium dependent ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 2), 'text':'Ras guanyl nucleotide'}, {'start':(22, 3), 'end':(22, 4), 'text':'releasing proteins'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 5), 'end':(22, 12), 'text':'( RasGRPs ) are a family of proteins'}, {'start':(22, 13), 'end':(22, 41), 'text':'that contain a DAG binding C1 domain , a Ras exchange motif domain , two EF-hands , and a guanine-nucleotide exchange factor ( GEF ) domain ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 22), 'text':'After PLCgamma activation , RasGRPs are recruited to the plasma membrane by binding to DAG for subsequent activation of Ras family proteins .'}, {'start':(24, 0), 'end':(24, 22), 'text':'Among the four RasGRP proteins , RasGRP1 has been shown to play an important role in TCR signaling and T cell development .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 18), 'text':'T cell development is partially blocked at the double positive stage in RasGRP1 -/ - mice ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 4), 'text':'Thymocytes from these mice show'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 5), 'end':(26, 24), 'text':'a complete lack of Erk activation in response to PMA , a DAG analogue , or TCR cross linking ,'}, {'start':(26, 25), 'end':(26, 34), 'text':'demonstrating that RasGRP1 links the TCR to Ras signaling .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 3), 'text':'It has been suggested'}, {'label':'joint', 'direction':'None', 'children':[{'start':(27, 4), 'end':(27, 7), 'text':'that RasGRP1 interacts with'}, {'start':(27, 8), 'end':(27, 21), 'text':'and activates Ras in the Golgi instead of the plasma membrane ( ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 6), 'text':'RasGRP2 is a candidate oncogene causing leukemia'}, {'start':(28, 7), 'end':(28, 11), 'text':'and regulates platelet activation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 7), 'text':'RasGRP3 is preferentially expressed in B cells .'}, {'start':(30, 0), 'end':(30, 8), 'text':'It is phosphorylated after BCR stimulation ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 8), 'text':'It has been demonstrated in the DT40 cell line'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 9), 'end':(31, 20), 'text':'that RasGRP3 is required for optimal activation of Erk upon BCR cross'}, {'start':(31, 21), 'end':(31, 24), 'text':'linking ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 9), 'text':'RasGRP4 is a new member of the RasGRP family .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 7), 'text':'It is highly expressed in myeloid cells ,'}, {'start':(33, 8), 'end':(33, 11), 'text':'including mast cells .'}]}, {'start':(34, 0), 'end':(34, 10), 'text':'It is not known whether RasGRP4 functions in mast cells .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 2), 'text':'Despite the fact'}, {'start':(35, 3), 'end':(35, 14), 'text':'that RasGRP1 plays an essential role in TCR mediated Ras-MAPK activation ,'}]}, {'start':(35, 15), 'end':(35, 29), 'text':'whether it functions in FcepsilonRI mediated signaling in mast cells has not been explored .'}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 5), 'text':'In this study , we demonstrate'}, {'start':(36, 6), 'end':(36, 21), 'text':'that RasGRP1 plays an important role in FcepsilonRI mediated PI3K activation and mast cell function .'}]}]}
0	1	{'start':(0, 0), 'end':(0, 13), 'text':'An essential role for RasGRP1 in mast cell function and IgE mediated allergic response'}
48	185	{'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'RESULTS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 5), 'text':'Expression of RasGRP1 in mast cells'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 13), 'text':'To assess the potential function of RasGRP1 in mast cells and allergic responses ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 14), 'end':(2, 16), 'text':'we first examined'}, {'start':(2, 17), 'end':(2, 24), 'text':'whether RasGRP1 is expressed in mast cells .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 1), 'text':'Bone marrow'}, {'start':(3, 2), 'end':(3, 4), 'text':'derived mast cells'}]}, {'start':(3, 5), 'end':(3, 22), 'text':'( BMMCs ) were derived from the bone marrow cells from WT and RasGRP1 -/ - mice .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 15), 'text':'After growing in medium with IL-3 for 3 wk , > 99 % of cultured cells'}, {'start':(4, 16), 'end':(4, 22), 'text':'were c-Kit + and FcepsilonRI + .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 16), 'text':'RasGRP1 -/ - cells expressed similar levels of c-Kit and FcepsilonRI as WT cells ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 17), 'end':(5, 17), 'text':'suggesting'}, {'start':(5, 18), 'end':(5, 30), 'text':'that RasGRP1 is dispensable for mast cell differentiation and maturation in vitro .'}]}]}, {'start':(6, 0), 'end':(6, 16), 'text':'These mast cells were used for detection of RasGRP1 protein and subsequent biochemical and functional assays .'}]}]}]}]}, {'start':(7, 0), 'end':(7, 19), 'text':'To detect RasGRP1 expression , lysates of WT and RasGRP1 -/ - mast cells were subjected to anti-RasGRP1 immunoprecipitation .'}]}, {'start':(8, 0), 'end':(8, 12), 'text':'Lysates from WT and RasGRP1 -/ - thymocytes were used as controls .'}]}, {'start':(9, 0), 'end':(9, 12), 'text':'The total lysates and immunoprecipitates were analyzed by an anti-RasGRP1 Western blot .'}]}, {'start':(10, 0), 'end':(10, 20), 'text':'As shown in , RasGRP1 protein was clearly detected in WT BMMCs , although not as abundant as in thymocytes .'}]}, {'start':(11, 0), 'end':(11, 13), 'text':'We also examined the expression of RasGRP4 by Western blotting with anti-RasGRP4 antibodies .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 3), 'text':'As reported previously ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 4), 'end':(12, 11), 'text':'mast cells expressed high amounts of RasGRP4 ,'}, {'start':(12, 12), 'end':(12, 20), 'text':'which was not detected in thymocytes ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 6), 'text':'RasGRP1 is required for mast cell degranulation'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 3), 'text':'Next , we investigated'}, {'start':(14, 4), 'end':(14, 11), 'text':'whether RasGRP1 functions in FcepsilonRI evoked degranulation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 5), 'text':'BMMCs were sensitized with anti-DNP IgE'}, {'start':(15, 6), 'end':(15, 25), 'text':'and stimulated with DNP-HSA at 1 , 10 , 100 , and 1,000 ng and ml to induce degranulation ,'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(15, 26), 'end':(15, 28), 'text':'which was determined'}, {'start':(15, 29), 'end':(15, 35), 'text':'by measuring the release of beta-hexosaminidase .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'As shown in ,'}, {'start':(16, 4), 'end':(16, 15), 'text':'FcepsilonRI evoked degranulation was markedly impaired in RasGRP1 -/ - BMMCs .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 7), 'text':'This defect was not due to their inability'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(17, 8), 'end':(17, 9), 'text':'to degranulate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 10), 'end':(17, 25), 'text':'because thapsigargin , a calcium ATPase inhibitor , was capable of inducing RasGRP1 -/ - BMMCs'}, {'start':(17, 26), 'end':(17, 30), 'text':'to degranulate ( ) .'}]}]}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 13), 'text':'To determine whether granule formation was normal in RasGRP1 -/ - mast cells ,'}, {'start':(18, 14), 'end':(18, 21), 'text':'we stained mast cells with toluidine blue .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 10), 'text':'Similar granules were seen in WT and RasGRP1 -/ - cells'}, {'start':(19, 11), 'end':(19, 15), 'text':'( not depicted ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 12), 'text':'Thus , defective signaling after FcepsilonRI engagement likely caused the diminished degranulation .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 7), 'text':'Impaired cytokine production in RasGRP1 -/ - BMMCs'}, {'start':(22, 0), 'end':(22, 20), 'text':'Upon FcepsilonRI cross linking , mast cells secrete cytokines , such as IL-6 , TNFalpha , IL-3 , and IL-4 .'}]}, {'start':(23, 0), 'end':(23, 12), 'text':'These cytokines play an important role in the allergic response ( ) .'}]}, {'start':(24, 0), 'end':(24, 13), 'text':'Next , we examined FcepsilonRI mediated cytokine production by RasGRP1 -/ - BMMCs .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 6), 'text':'Total RNAs were prepared from mast cells'}, {'start':(25, 7), 'end':(25, 10), 'text':'activated for 1 h'}]}, {'start':(25, 11), 'end':(25, 16), 'text':'and were used in RT-PCR .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 5), 'text':'Amplification of the beta-actin transcript indicated'}, {'start':(26, 6), 'end':(26, 15), 'text':'that similar amounts of cDNAs were used ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 7), 'text':'Although IL-6 RNA synthesis was reduced slightly ,'}, {'start':(27, 8), 'end':(27, 26), 'text':'transcription of TNFalpha , IL-4 , and IL-3 was significantly decreased in RasGRP1 -/ - BMMCs ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 8), 'text':'These results were further confirmed by quantitation of cytokines'}, {'start':(28, 9), 'end':(28, 19), 'text':'secreted into the culture medium at 8 h after stimulation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 6), 'text':'Although IL-6 production was relatively normal ,'}, {'start':(29, 7), 'end':(29, 27), 'text':'secretion of TNFalpha , IL-3 , and IL-4 by RasGRP1 -/ - cells after stimulation was significantly reduced ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(30, 0), 'end':(30, 2), 'text':'These results indicated'}, {'start':(30, 3), 'end':(30, 13), 'text':'that RasGRP1 is required for cytokine production upon FcepsilonRI engagement .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 8), 'text':'Severely defective systemic anaphylaxis in RasGRP1 -/ - mice'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 12), 'text':'To investigate the impact of RasGRP1 inactivation on allergic response in vivo ,'}, {'start':(32, 13), 'end':(32, 26), 'text':'we performed IgE evoked systemic anaphylaxis on WT and RasGRP1 -/ - mice .'}]}]}, {'start':(33, 0), 'end':(33, 16), 'text':'Anti-DNP IgE was intravenously injected into mice 24 h before challenge by systemic administration of DNP-HSA .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 12), 'text':'At 1.5 min after challenge , blood was harvested from these mice .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 3), 'text':'The concentration of histamine'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 4), 'end':(35, 13), 'text':'released into the blood was then measured to evaluate IgE'}, {'start':(35, 14), 'end':(35, 17), 'text':'initiated allergic response .'}]}]}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 17), 'text':'A dramatic reduction ( > 95 % ) in histamine release was observed in RasGRP1 -/ - mice'}, {'start':(36, 18), 'end':(36, 26), 'text':'compared with that in WT mice ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 23), 'text':'To assess whether the severe defect in systemic anaphylaxis was due to a developmental defect of mast cells in RasGRP1 -/ - mice ,'}, {'start':(37, 24), 'end':(37, 36), 'text':'we determined the distribution of mast cells in RasGRP1 -/ - mice .'}]}, {'start':(38, 0), 'end':(38, 26), 'text':'Comparable numbers of mast cells were detected in the ear and back skin dermis ( and not depicted ) in WT and RasGRP1 -/ - mice .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 10), 'text':'Similar percentages of mast cells were also detected in peritoneal cavities'}, {'start':(39, 11), 'end':(39, 19), 'text':'using toluidine blue staining and flow cytometry analysis .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(40, 0), 'end':(40, 10), 'text':'Normal numbers of mast cells in RasGRP1 -/ - mice indicated'}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 11), 'end':(40, 19), 'text':'that RasGRP1 is not required during mast cell development'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 20), 'end':(40, 23), 'text':'and excluded the possibility'}, {'start':(40, 24), 'end':(40, 36), 'text':'that the defective anaphylaxis is a consequence of mast cell developmental defects .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 7), 'text':'This conclusion was consistent with our biochemical data'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(41, 8), 'end':(41, 8), 'text':'showing'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 9), 'end':(41, 28), 'text':'that stem cell factor ( SCF ) or IL-3-mediated Erk and Akt activation was normal in RasGRP1 -/ - BMMCs'}, {'start':(41, 29), 'end':(41, 33), 'text':'( not depicted ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(42, 0), 'end':(42, 9), 'text':'Therefore , our in vivo and in vitro data suggested'}, {'start':(42, 10), 'end':(42, 25), 'text':'that RasGRP1 plays an important role in FcepsilonRI initiated mast cell degranulation and systemic anaphylaxis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 8), 'text':'FcepsilonRI mediated proximal signaling in RasGRP1 -/ - BMMCs'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 2), 'text':'Our data suggested'}, {'start':(44, 3), 'end':(44, 21), 'text':'that defective intracellular signaling might be responsible for the impaired degranulation and anaphylaxis in the absence of RasGRP1 .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 0), 'end':(45, 2), 'text':'We next investigated'}, {'start':(45, 3), 'end':(45, 16), 'text':'whether FcepsilonRI evoked signaling events are affected in RasGRP1 -/ - mast cells .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(46, 0), 'end':(46, 5), 'text':'BMMCs were sensitized with anti-DNP IgE'}, {'start':(46, 6), 'end':(46, 28), 'text':'and activated with DNP-HSA for 0 , 2 , 5 , 10 , and 20 min or with PMA for 5 min .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(47, 0), 'end':(47, 3), 'text':'Total lysates were prepared'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 4), 'end':(47, 11), 'text':'and analyzed by Western blotting with different antibodies'}, {'start':(47, 12), 'end':(47, 15), 'text':'as indicated in .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 14), 'text':'Tyrosine phosphorylation of proteins was relatively normal in RasGRP1 -/ - cells ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 6), 'text':'Because of the important role of LAT'}, {'start':(49, 7), 'end':(49, 16), 'text':'in organizing the signaling complexes downstream of the FcepsilonRI ,'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(49, 17), 'end':(49, 21), 'text':'we examined phosphorylation of LAT'}, {'start':(49, 22), 'end':(49, 28), 'text':'by blotting with an anti-LATpY191 antibody .'}]}]}, {'start':(50, 0), 'end':(50, 12), 'text':'Normal LAT phosphorylation was detected in RasGRP1 -/ - BMMCs ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 18), 'text':'Tyrosine phosphorylation of PLCgamma1 and PLCgamma2 was also comparable in WT and RasGRP1 -/ - BMMCs ( ) .'}, {'start':(52, 0), 'end':(52, 23), 'text':'In agreement with normal phosphorylation of PLCgamma1 and PLCgamma2 , FcepsilonRI initiated calcium influx was intact in RasGRP1 -/ - BMMCs ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 6), 'text':'These results were consistent with previous reports'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(53, 7), 'end':(53, 7), 'text':'showing'}, {'start':(53, 8), 'end':(53, 14), 'text':'that RasGRP1 functions downstream of PLCgamma .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 7), 'text':'MAPK activation in RasGRP1 -/ - mast cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 6), 'text':'RasGRP1 has an established role in TCR'}, {'start':(55, 7), 'end':(55, 10), 'text':'mediated Ras-Erk activation .'}]}]}, {'start':(56, 0), 'end':(56, 16), 'text':'It is also required in PMA ( a DAG analogue ) -induced Erk activation ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(57, 0), 'end':(57, 7), 'text':'Because RasGRP1 was expressed in mast cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(57, 8), 'end':(57, 10), 'text':'we next examined'}, {'start':(57, 11), 'end':(57, 22), 'text':'whether the Ras-Erk pathway was affected in the absence of RasGRP1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 28), 'text':'Surprisingly , in contrast with the defective Erk activation in RasGRP1 -/ - thymocytes , FcepsilonRI mediated Erk activation was normal in RasGRP1 -/ - BMMCs ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(59, 0), 'end':(59, 2), 'text':'These data indicated'}, {'start':(59, 3), 'end':(59, 16), 'text':'that RasGRP1 is not required for Ras-Erk activation in the FcepsilonRI signaling pathway .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(60, 0), 'end':(60, 2), 'text':'It is possible'}, {'start':(60, 3), 'end':(60, 30), 'text':'that other Ras guanyl nucleotide exchange factors , such as Sos , or other members of the RasGRP family may be the primary activators of this pathway .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 18), 'text':'Jnk and p38 were previously shown to be important for production of certain cytokines , such as IL-6 .'}, {'start':(62, 0), 'end':(62, 14), 'text':'We also examined Jnk and p38 activation by Western blotting with anti-phospho-Jnk and p38 .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(63, 0), 'end':(63, 19), 'text':'No differences in the activation of these MAPKs were observed between WT and RasGRP1 -/ - BMMCs ( ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 0), 'end':(64, 17), 'text':'In addition , PMA induced MAPK activation was also normal in the absence of RasGRP1 ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(65, 0), 'end':(65, 4), 'text':'Collectively , these data suggested'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 5), 'end':(65, 11), 'text':'that RasGRP1 is not required in FcepsilonRI'}, {'start':(65, 12), 'end':(65, 15), 'text':'mediated MAPK activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 4), 'text':'Diminished activation of PI3K pathway'}, {'start':(67, 0), 'end':(67, 15), 'text':'PI3K and its downstream signaling pathway play important roles in mast cell function and development .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(68, 0), 'end':(68, 13), 'text':'Genetic inactivation of the p110delta isoform of PI3K leads to defective mast cell development'}, {'start':(68, 14), 'end':(68, 24), 'text':'and reduced IgE induced degranulation and cytokine release ( ) .'}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(69, 0), 'end':(69, 1), 'text':'We asked'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 2), 'end':(69, 15), 'text':'whether RasGRP1 could be involved in the activation of the PI3K pathway in FcepsilonRI'}, {'start':(69, 16), 'end':(69, 18), 'text':'evoked signaling .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(70, 0), 'end':(70, 10), 'text':'To assess the effect of RasGRP1 deficiency on PI3K activation ,'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(70, 11), 'end':(70, 16), 'text':'we first assayed the PI3K activity'}, {'start':(70, 17), 'end':(70, 26), 'text':'by determining production of PIP 3 after FcepsilonRI stimulation .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(71, 0), 'end':(71, 19), 'text':'32 P labeled mast cells were stimulated with DNP-HSA for 0 , 2 , 5 , and 10 min ,'}, {'start':(71, 20), 'end':(71, 31), 'text':'and lipid fractions were extracted and separated by thin layer chromatography .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 20), 'text':'WT BMMCs had a threefold increase of PIP 3 at 2 min after FcepsilonRI stimulation ; however , RasGRP1 -/ -'}, {'start':(72, 21), 'end':(72, 31), 'text':'cells only had an increase of 50 % ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 0), 'end':(73, 25), 'text':'The residual PI3K activity in RasGRP1 -/ - BMMCs might be due to the compensation of RasGRP1 function by other members of the RasGRP family .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(74, 0), 'end':(74, 4), 'text':'A previous study has shown'}, {'start':(74, 5), 'end':(74, 20), 'text':'that the membrane recruitment of PI3K by Gab2 is required for its activation ( ) .'}]}, {'start':(75, 0), 'end':(75, 9), 'text':'We examined Gab2 phosphorylation and its interaction with p85 .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(76, 0), 'end':(76, 3), 'text':'Gab2 was phosphorylated normally'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 4), 'end':(76, 15), 'text':'and interacted with p85 in RasGRP1 -/ - BMMCs ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(76, 16), 'end':(76, 16), 'text':'suggesting'}, {'start':(76, 17), 'end':(76, 34), 'text':'that RasGRP1 likely controls PI3K activation through a mechanism other than regulating its membrane recruitment by Gab2 .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 8), 'text':'SHIP acts as a gatekeeper of mast cell degranulation'}, {'start':(77, 9), 'end':(77, 15), 'text':'through hydrolyzing PIP 3 ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(78, 0), 'end':(78, 21), 'text':'To investigate whether decreased PIP 3 production in RasGRP1 -/ - cells was caused by increased SHIP activation in RasGRP1 -/ -'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(78, 22), 'end':(78, 24), 'text':'mast cells ,'}, {'start':(78, 25), 'end':(78, 31), 'text':'we examined SHIP expression and phosphorylation .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(79, 0), 'end':(79, 14), 'text':'No substantial differences were seen between WT and RasGRP1 -/ - cells ( ) .'}, {'start':(80, 0), 'end':(80, 18), 'text':'We next investigated the impact of impaired PI3K activation on the phosphorylation of molecules in the PI3K pathway .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(81, 0), 'end':(81, 9), 'text':'Akt is recruited to the cell membrane by PIP 3'}, {'start':(81, 10), 'end':(81, 16), 'text':'and phosphorylated by PDK1 ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(82, 0), 'end':(82, 5), 'text':'After activation , Akt phosphorylates GSK3beta'}, {'start':(82, 6), 'end':(82, 10), 'text':'and inhibits its activity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(83, 0), 'end':(83, 12), 'text':'Akt and GSK3beta are critical in FcepsilonRI induced production of TNFalpha and IL-2'}, {'start':(83, 13), 'end':(83, 27), 'text':'by regulating the transcriptional activity of NF-kappaB , NFAT , and AP-1 ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(84, 0), 'end':(84, 10), 'text':'We examined Akt activation by Western blotting with antibodies against Akt'}, {'start':(84, 11), 'end':(84, 20), 'text':'phosphorylated at Ser473 ( ) or Thr308 ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(85, 0), 'end':(85, 16), 'text':'FcepsilonRI mediated Akt phosphorylation at these two residues was significantly reduced in RasGRP1 -/ - BMMCs .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 0), 'end':(86, 17), 'text':'The phosphorylation of GSK3beta ( Ser9 ) was also decreased in RasGRP1 -/ - BMMCs ( ) .'}, {'start':(87, 0), 'end':(87, 13), 'text':'These results could explain the reduced cytokine production in RasGRP1 -/ - cells .'}]}]}]}]}]}]}]}]}, {'start':(88, 0), 'end':(88, 8), 'text':'Another molecule downstream of PI3K activation is PDK1 .'}]}, {'label':'cause', 'direction':'RightToLeft', 'children':[{'start':(89, 0), 'end':(89, 16), 'text':'Consistent with reduced PIP 3 production , phosphorylation of PDK1 was also markedly diminished ( ) .'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(90, 0), 'end':(90, 12), 'text':'As a result of the defective PI3K pathway , phosphorylation of PKCdelta ,'}, {'start':(90, 13), 'end':(90, 20), 'text':'which is mediated by PDK1 ( ) ,'}]}, {'start':(90, 21), 'end':(90, 26), 'text':'was significantly diminished ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 0), 'end':(91, 24), 'text':'Defective activation of Akt , PDK1 , and PKCdelta in RasGRP1 -/ - cells could not be bypassed by stimulation with PMA ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(91, 25), 'end':(91, 25), 'text':'suggesting'}, {'start':(91, 26), 'end':(91, 36), 'text':'that RasGRP1 is required for signaling downstream of DAG production .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(92, 0), 'end':(92, 4), 'text':'Collectively , these data indicated'}, {'start':(92, 5), 'end':(92, 18), 'text':'that activation of molecules in the PI3K pathway is affected by RasGRP1 deficiency .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 0), 'end':(93, 6), 'text':'N-Ras mediates regulation of PI3K by RasGRP1'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(94, 0), 'end':(94, 9), 'text':'To examine whether FcepsilonRI mediated Ras activation was normal ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(94, 10), 'end':(94, 14), 'text':'we performed a Ras assay'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(94, 15), 'end':(94, 18), 'text':'using the GST protein'}, {'start':(94, 19), 'end':(94, 33), 'text':'fused with the Ras binding domain ( RBD ) of Raf ( GST-Raf-RBD ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(95, 0), 'end':(95, 3), 'text':'GTP bound Ras proteins'}, {'start':(95, 4), 'end':(95, 23), 'text':'precipitated by GST-Raf-RBD were detected by Western blotting with antibodies against H-Ras , N-Ras , and K-Ras , respectively .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(96, 0), 'end':(96, 9), 'text':'As shown in , the amount of GTP bound N-Ras'}, {'start':(96, 10), 'end':(96, 20), 'text':'precipitated by GST-Raf-RBD was reduced in RasGRP1 -/ - cells ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(96, 21), 'end':(96, 26), 'text':'whereas the amount of GTP bound'}, {'start':(96, 27), 'end':(96, 37), 'text':'K-Ras was similar in WT and RasGRP1 -/ - cells .'}]}]}]}]}, {'start':(97, 0), 'end':(97, 10), 'text':'GTP bound H-Ras was not detected ( not depicted ) .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(98, 0), 'end':(98, 2), 'text':'These data indicated'}, {'start':(98, 3), 'end':(98, 14), 'text':'that RasGRP1 is likely required for N-Ras activation in FcepsilonRI signaling .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(99, 0), 'end':(99, 17), 'text':'To determine whether the reduced N-Ras activation was indeed the cause for defective PI3K activation and degranulation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(99, 18), 'end':(99, 23), 'text':'we introduced the constitutively activated forms'}, {'start':(99, 24), 'end':(99, 42), 'text':'( G12V ) of N-Ras , K-Ras , and H-Ras into RasGRP1 -/ - BMMCs by retroviral transduction .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(100, 0), 'end':(100, 3), 'text':'Stable transductants were selected'}, {'start':(100, 4), 'end':(100, 6), 'text':'and expanded .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(101, 0), 'end':(101, 3), 'text':'First , we examined'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(101, 4), 'end':(101, 9), 'text':'whether PI3K activation could be restored'}, {'start':(101, 10), 'end':(101, 14), 'text':'by detecting Akt activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(102, 0), 'end':(102, 3), 'text':'As shown in ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(102, 4), 'end':(102, 11), 'text':'phosphorylation of Akt in RasGRP1 -/ - cells'}, {'start':(102, 12), 'end':(102, 14), 'text':'expressing G12V N-Ras'}]}, {'start':(102, 15), 'end':(102, 22), 'text':'was similar to that in WT cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(103, 0), 'end':(103, 13), 'text':'Expression of G12V K-Ras slightly enhanced Akt phosphorylation in RasGRP1 -/ - cells ,'}, {'start':(103, 14), 'end':(103, 22), 'text':'whereas expression of G12V H-Ras had no effect .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(104, 0), 'end':(104, 7), 'text':'These Ras proteins were expressed at comparable amounts'}, {'start':(104, 8), 'end':(104, 20), 'text':'as detected by an antibody against the HA epitope tag ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(105, 0), 'end':(105, 3), 'text':'Next , we assayed'}, {'start':(105, 4), 'end':(105, 20), 'text':'whether the defects in FcepsilonRI mediated degranulation could be corrected by expression of constitutively active Ras .'}]}, {'start':(106, 0), 'end':(106, 10), 'text':'We performed the beta-hexosaminidase release assay with transduced mast cells .'}]}, {'start':(107, 0), 'end':(107, 22), 'text':'Although G12V N-Ras rescued the defective degranulation in RasGRP1 -/ - BMMCs , G12V K-Ras or H-Ras had little effect ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(108, 0), 'end':(108, 2), 'text':'These data indicated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(108, 3), 'end':(108, 8), 'text':'that N-Ras is the Ras member'}, {'start':(108, 9), 'end':(108, 17), 'text':'that is activated by RasGRP1 in mast cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(109, 0), 'end':(109, 7), 'text':'Impaired granule translocation in RasGRP1 -/ - BMMCs'}, {'start':(110, 0), 'end':(110, 8), 'text':'Degranulation is thought to be a two-step process .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(111, 0), 'end':(111, 8), 'text':'After granules are translocated to the plasma membrane ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(111, 9), 'end':(111, 15), 'text':'they are fused with the plasma membrane'}, {'start':(111, 16), 'end':(111, 22), 'text':'to release their contents ( ) .'}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(112, 0), 'end':(112, 5), 'text':'To visualize the granule release ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(112, 6), 'end':(112, 13), 'text':'we introduced a CD63-GFP fusion protein into BMMCs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(112, 14), 'end':(112, 21), 'text':'and monitored granule movement under a confocal microscope'}, {'start':(112, 22), 'end':(112, 27), 'text':'as described previously ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(113, 0), 'end':(113, 10), 'text':'CD63 is mainly localized in the granules of mast cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'RightToLeft', 'children':[{'start':(114, 0), 'end':(114, 5), 'text':'Before cross linking with DNP-HSA ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(114, 6), 'end':(114, 9), 'text':'mast cell granules ,'}, {'start':(114, 10), 'end':(114, 16), 'text':'as revealed by the CD63-GFP fluorescence ,'}]}, {'start':(114, 17), 'end':(114, 22), 'text':'were mostly in the cytosol .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(115, 0), 'end':(115, 17), 'text':'After cross linking , the majority of granules moved close to the plasma membrane in WT BMMCs .'}, {'start':(116, 0), 'end':(116, 19), 'text':'In contrast , granules in RasGRP1 -/ - cells still remained in the cytosol after FcepsilonRI aggregation ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(117, 0), 'end':(117, 8), 'text':'After granules are fused with the plasma membrane ,'}, {'start':(117, 9), 'end':(117, 19), 'text':'CD63 can be detected at the cell surface ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(118, 0), 'end':(118, 19), 'text':'We also examined CD63 surface expression in WT and RasGRP1 -/ - cells by staining cells with an anti-CD63 antibody'}, {'start':(118, 20), 'end':(118, 24), 'text':'followed by FACS analysis .'}]}]}]}]}, {'start':(119, 0), 'end':(119, 23), 'text':'We detected an increase of CD63 surface expression on WT cells but a very minimal increase on RasGRP1 -/ - cells ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(120, 0), 'end':(120, 2), 'text':'These data indicated'}, {'start':(120, 3), 'end':(120, 13), 'text':'that RasGRP1 is critical for granule movement in mast cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(121, 0), 'end':(121, 13), 'text':'Without RasGRP1 , mast cells failed to move their granules to the plasma membrane'}, {'start':(121, 14), 'end':(121, 18), 'text':'to release their contents .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(122, 0), 'end':(122, 6), 'text':'Cytoskeleton rearrangement in RasGRP1 -/ - BMMCs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(123, 0), 'end':(123, 4), 'text':'FcepsilonRI engagement induces cytoskeleton rearrangement'}, {'start':(123, 5), 'end':(123, 14), 'text':'that includes microtubule formation and disassembly of F-actin ring .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(124, 0), 'end':(124, 7), 'text':'Granule translocation and degranulation require microtubule formation .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(125, 0), 'end':(125, 12), 'text':'To investigate why granules failed to translocate in RasGRP1 -/ - BMMCs ,'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(125, 13), 'end':(125, 23), 'text':'we examined formation of microtubule and disassembly of the F-actin structures'}, {'start':(125, 24), 'end':(125, 39), 'text':'by staining BMMCs with anti-alpha-tubulin and rhodamine-phalloidin , respectively , before and after FcepsilonRI engagement .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(126, 0), 'end':(126, 31), 'text':'Cross linking of sensitized WT mast cells with DNP-HSA intensified network like staining ( green ) of tubulin in the cytosol , an indication of the formation of microtubules ( ) .'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(127, 0), 'end':(127, 6), 'text':'In the meantime , F-actin ring ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(127, 7), 'end':(127, 10), 'text':'indicated by phalloidin staining'}, {'start':(127, 11), 'end':(127, 14), 'text':'( red ) ,'}]}]}, {'start':(127, 15), 'end':(127, 18), 'text':'collapsed after stimulation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(128, 0), 'end':(128, 22), 'text':'In activated RasGRP1 -/ - BMMCs , fluorescence from anti-tubulin staining was only seen near the plasma membrane as in unstimulated cells ,'}, {'start':(128, 23), 'end':(128, 30), 'text':'whereas F-actin disassembly was normal ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(129, 0), 'end':(129, 2), 'text':'These results indicated'}, {'start':(129, 3), 'end':(129, 17), 'text':'that RasGRP1 mediated signaling is required for the formation of microtubules after FcepsilonRI engagement .'}]}, {'start':(130, 0), 'end':(130, 13), 'text':'Rac and Rho GTPases can regulate cytoskeletal organization in eukaryotic cells ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(131, 0), 'end':(131, 20), 'text':'Recently , RhoA activation has been shown to be important for microtubule formation and degranulation in mast cells ( ) .'}, {'start':(132, 0), 'end':(132, 15), 'text':'PI3K and its products are required for activation of Rho family proteins in several pathways .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(133, 0), 'end':(133, 8), 'text':'We next examined the activation of Rac1 and RhoA'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(133, 9), 'end':(133, 20), 'text':'by using GST-PAK-PBD and GST-Rhotekin RBD fusion proteins to pull down GTP'}, {'start':(133, 21), 'end':(133, 25), 'text':'bound Rac1 and RhoA .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(134, 0), 'end':(134, 3), 'text':'As shown in ,'}, {'start':(134, 4), 'end':(134, 19), 'text':'activation of Rac1 in RasGRP1 -/ - cells was similar to that in WT cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(135, 0), 'end':(135, 12), 'text':'However , activation of RhoA was reduced in RasGRP1 -/ - cells .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(136, 0), 'end':(136, 2), 'text':'These results suggested'}, {'start':(136, 3), 'end':(136, 14), 'text':'that RasGRP1 plays an important role in FcepsilonRI mediated RhoA activation .'}]}]}]}]}]}]}]}]}]}]}
1	11	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 20), 'text':'Cross linking of the FcepsilonRI activates the phosphatidyl inositol 3 kinase ( PI3K ) and mitogen activated protein kinase pathways .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 2), 'text':'Previous studies demonstrate'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(1, 3), 'end':(1, 6), 'text':'that Ras guanyl nucleotide'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 7), 'end':(1, 8), 'text':'releasing protein'}, {'start':(1, 9), 'end':(1, 22), 'text':'( RasGRP ) 1 is essential in T cell receptor mediated Ras-Erk activation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 3), 'text':'Here , we report'}, {'start':(2, 4), 'end':(2, 19), 'text':'that RasGRP1 plays an important role in FcepsilonRI mediated PI3K activation and mast cell function .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 9), 'text':'RasGRP1 deficient mice failed to mount anaphylactic allergic reactions .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 12), 'text':'RasGRP1 -/ - mast cells had markedly reduced degranulation and cytokine production .'}, {'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 7), 'text':'Although FcepsilonRI mediated Erk activation was normal ,'}, {'start':(5, 8), 'end':(5, 12), 'text':'PI3K activation was diminished .'}]}, {'start':(6, 0), 'end':(6, 18), 'text':'Consequently , activation of Akt , PIP 3 -dependent kinase , and protein kinase C delta was defective .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 16), 'text':'Expression of a constitutively active form of N-Ras could rescue the degranulation defect and Akt activation .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 2), 'text':'We further demonstrated'}, {'start':(8, 3), 'end':(8, 21), 'text':'that RasGRP1 -/ - mast cells were defective in granule translocation , microtubule formation , and RhoA activation .'}]}]}, {'start':(9, 0), 'end':(9, 12), 'text':'Our results identified RasGRP1 as an essential regulator of mast cell function .'}]}]}]}]}
243	296	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'MATERIALS AND METHODS'}, {'start':(1, 0), 'end':(1, 3), 'text':'Mice and antibodies .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 16), 'text':'RasGRP1 -/ - mice were provided by J.C. Stone ( University of Alberta , Canada ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 7), 'text':'Mice were housed in specific pathogen-free conditions ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 8), 'end':(3, 15), 'text':'and the use of mice in the experiments'}, {'start':(3, 16), 'end':(3, 30), 'text':'described in this study was approved by the Duke University Institutional Animal Care Committee .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 8), 'text':'The following antibodies were used in this study :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 9), 'end':(4, 13), 'text':'anti-DNP IgE ( SPE-7 ;'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 14), 'end':(4, 24), 'text':'Sigma-Aldrich ) , FcepsilonRIalpha , and c-Kit ( eBioscience ) ;'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 25), 'end':(4, 60), 'text':'PLCgamma2 , Erk2 , K-Ras , RhoA , and RasGRP1 ( Santa Cruz Biotechnology , Inc. ) , p85 , pTyr ( 4G10 ) , PLCgamma1 , Rac1 , and phospho-LATpY191 ( Upstate Biotechnology ) ;'}, {'start':(4, 61), 'end':(4, 68), 'text':'and pan-Ras and N-Ras ( Calbiochem ) .'}]}]}]}]}, {'start':(5, 0), 'end':(5, 19), 'text':'AKT , Jnk , p38 , PKCdelta , PDK1 , and other phospho specific antibodies were from Cell Signaling .'}]}]}]}, {'start':(6, 0), 'end':(6, 9), 'text':'Anti-LAT ( 11B12 ) was described previously ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 3), 'text':'Anti-RasGRP4 sera were raised'}, {'start':(7, 4), 'end':(7, 12), 'text':'by immunizing rabbits with a GST-RasGRP4 fusion protein .'}]}, {'start':(8, 0), 'end':(8, 8), 'text':'Mast cell culture , stimulation , and degranulation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 14), 'text':'Bone marrow cells were taken from the femurs of WT and RasGRP1 -/ - mice'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 15), 'end':(9, 19), 'text':'and were cultured in IMDM'}, {'start':(9, 20), 'end':(9, 48), 'text':'supplemented with 10 % FBS , beta-mercaptoethanol , penicillin , and streptomycin in the presence of 5 ng and ml of recombinant IL-3 at 37degreesC for 3-6 wk .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 25), 'text':'For stimulation through the FcepsilonRI , 2 x 10 6 / ml mast cells were sensitized with 0.5 mug and ml anti-DNP IgE in IMDM medium'}, {'start':(10, 26), 'end':(10, 48), 'text':'without IL-3 for 4 h overnight before stimulation with 20 ng and ml DNP-HSA for the indicated time points in each figure .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 14), 'text':'For IL-3 or SCF stimulation , cells were starved for 24 h in IMDM medium'}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 15), 'end':(11, 16), 'text':'without IL-3'}, {'start':(11, 17), 'end':(11, 29), 'text':'and stimulated with 20 ng and ml IL-3 or SCF , respectively .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 4), 'text':'Mast cell degranulation was performed'}, {'start':(12, 5), 'end':(12, 10), 'text':'as described previously ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 17), 'text':'For systemic anaphylaxis , WT and RasGRP1 -/ - mice were sensitized with anti-DNP IgE for 24 h'}, {'start':(13, 18), 'end':(13, 25), 'text':'and challenged with DNP-HSA for 1.5 min .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 6), 'text':'Blood was collected by cardiac puncture ,'}, {'start':(14, 7), 'end':(14, 17), 'text':'and histamine concentration in the blood was determined by ELISA .'}]}]}]}]}]}]}, {'start':(15, 0), 'end':(15, 2), 'text':'Western blotting .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 18), 'text':'Cells were lysed in RIPA buffer for analysis of whole cell lysates or Brij lysis buffer for immunoprecipitation .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 8), 'text':'For Western blotting , samples were separated by SDS-PAGE'}, {'start':(17, 9), 'end':(17, 14), 'text':'and transferred onto nitrocellulose membranes .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 7), 'text':'After blocking with 1 % fish gelatin ,'}, {'start':(18, 8), 'end':(18, 14), 'text':'membranes were incubated with primary antibodies ,'}]}, {'start':(18, 15), 'end':(18, 18), 'text':'washed three times ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 19), 'end':(18, 27), 'text':'and probed with either goat anti-mouse or anti-rabbit Ig'}, {'start':(18, 28), 'end':(18, 42), 'text':'conjugated with Alexa Fluor 680 ( Invitrogen ) or IRDye 800 ( Rockland ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 11), 'text':'Membranes were then visualized and quantified with an infrared fluorescence imaging system'}, {'start':(19, 12), 'end':(19, 18), 'text':'( LI-COR Bioscience Odyssey system ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 0), 'end':(20, 11), 'text':'For most of Western blots , samples were resolved on multiple gels'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(20, 12), 'end':(20, 13), 'text':'and analyzed'}, {'start':(20, 14), 'end':(20, 19), 'text':'by immunoblotting with different antibodies .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 4), 'text':'Numeration of mast cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 7), 'text':'Peritoneal flushes were stained with toluidine blue .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 23), 'text':'Percentages of mast cells in the peritoneum were calculated as mast cell numbers to total cell numbers in five fields under 200x magnification .'}, {'start':(24, 0), 'end':(24, 14), 'text':'Skin sections from the back skin and ear dermis were stained with toluidine blue .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 28), 'text':'Mast cell numbers were counted from at least five sections from each WT ( n = 3 ) and RasGRP1 -/ - mouse ( n = 3 ) .'}, {'start':(26, 0), 'end':(26, 8), 'text':'Data are presented as mean + /- SD .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 10), 'text':'Calcium influx , cytokine production , and PIP 3 measurement .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 16), 'text':'For calcium influx , cells were sensitized with 0.5 mug and ml anti-DNP IgE for 4 h'}, {'start':(28, 17), 'end':(28, 33), 'text':'and loaded with 1.5 muM Indo-1 in 1 % FBS-HBSS media for 30 min at 30degreesC .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 8), 'text':'Cells were stimulated with 30 ng and ml DNP-HSA'}, {'start':(29, 9), 'end':(29, 13), 'text':'to induce calcium flux .'}]}, {'start':(30, 0), 'end':(30, 12), 'text':'The fluorescence emission ratio at 405-495 nm was monitored by flow cytometry .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 9), 'text':'For cytokine production , 2 x 10 6 anti-DNP IgE'}, {'start':(31, 10), 'end':(31, 11), 'text':'sensitized cells'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 12), 'end':(31, 29), 'text':'were stimulated with DNP-HSA for 1 h for RT-PCR and for 8 h for the measurement of cytokines'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 30), 'end':(31, 32), 'text':'released into supernatants'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 33), 'end':(31, 37), 'text':'using a Bio-Plex cytokine assay'}, {'start':(31, 38), 'end':(31, 42), 'text':'( Bio-Rad Laboratories ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 7), 'text':'PIP 3 production was determined using a protocol'}, {'start':(32, 8), 'end':(32, 12), 'text':'described previously ( ) .'}]}, {'start':(33, 0), 'end':(33, 7), 'text':'Ras , Rac1 , and RhoA activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 16), 'text':'For Ras activation , 2 x 10 7 / ml mast cells were lysed in a buffer'}, {'start':(34, 17), 'end':(34, 58), 'text':'containing 25 mM Hepes , pH 7.5 , 150 mM NaCl , 1 % NP-40 , 0.25 % sodium deoxycholate , 10 % glycerol , 10 mM MgCl 2 , 1 mM EDTA , and 1 mM Na 3 VO 4 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 14), 'text':'The lysates were incubated with 20 mug GST-Raf-RBD on glutathione beads for 40 min .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'Beads were washed'}, {'start':(36, 3), 'end':(36, 10), 'text':'and boiled in 1x SDS sample buffer .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 10), 'text':'GST-Rhotekin RBD and GST-PAK-PBD fusion protein were provided by K. Burridge'}, {'start':(37, 11), 'end':(37, 22), 'text':'( University of North Carolina , Chapel Hill , NC ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 8), 'text':'Rac1 and RhoA activation was examined by pull-down assays'}, {'start':(38, 9), 'end':(38, 14), 'text':'as described previously ( ) .'}]}]}]}, {'start':(39, 0), 'end':(39, 28), 'text':'GTP bound pan-Ras , H-Ras , K-Ras , N-Ras , Rac1 , and RhoA were detected by Western blotting with antibodies against each of these proteins , respectively .'}]}]}, {'start':(40, 0), 'end':(40, 5), 'text':'Ras reconstitution by retroviral transduction .'}]}, {'start':(41, 0), 'end':(41, 25), 'text':'Constitutively active forms ( G12V ) of H-Ras , K-Ras , and N-Ras with an HA tag were subcloned into a retroviral vector , pMSCV/IRES/Bla .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 4), 'text':'The retroviral plasmids were used'}, {'start':(42, 5), 'end':(42, 12), 'text':'to transfect Phoenix cells for retrovirus packaging .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 9), 'text':'12-d-old BMMCs were transduced with retroviruses by spin infection .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 0), 'end':(44, 13), 'text':'48 h after transduction , cells were selected with 5 mug and ml blasticidin'}, {'start':(44, 14), 'end':(44, 22), 'text':'and expanded for 10-14 d for subsequent experiments .'}]}]}]}, {'start':(45, 0), 'end':(45, 5), 'text':'Granule translocation and cytoskeletal rearrangement .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 8), 'text':'Examination of granule translocation by confocal microscopy was performed'}, {'start':(46, 9), 'end':(46, 14), 'text':'as described previously ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 19), 'text':'In brief , BMMCs were transduced with pMX-CD63GFP retroviruses at day 5 after bone marrow culture in IL-3 medium .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(48, 0), 'end':(48, 13), 'text':'At 3 wk after the initial culture , BMMCs were sensitized with anti-DNP IgE'}, {'start':(48, 14), 'end':(48, 21), 'text':'and stimulated with DNP-HSA for 10 min .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 9), 'text':'Cells were immediately fixed with 4 % paraformaldehyde before cytospin'}, {'start':(49, 10), 'end':(49, 15), 'text':'and visualized by confocal microscopy .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 9), 'text':'For cytoskeletal rearrangement , cells were permeabilized in a buffer'}, {'start':(50, 10), 'end':(50, 37), 'text':'containing 0.1 % saponin ( 2 % FBS , 1 % BSA , and 0.02 % sodium azide in PBS ) for 20 min at room temperature .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(51, 0), 'end':(51, 13), 'text':'After cytospin , cells were stained with anti-alpha-tubulin ( Sigma-Aldrich ) at 1:50 dilution'}, {'start':(51, 14), 'end':(51, 29), 'text':'and incubated with Alexa Fluor 488 goat anti-mouse IgG and rhodamine phalloidin ( Invitrogen ) .'}]}]}, {'start':(52, 0), 'end':(52, 10), 'text':'Confocal microscopy was performed using a Zeiss LSM410 confocal system .'}]}]}]}]}]}]}]}]}
185	243	{'label':'topic-change', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'DISCUSSION'}, {'start':(1, 0), 'end':(1, 14), 'text':'Disruption of RasGRP1 had no effect on the proximal signaling events after FcepsilonRI engagement .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 26), 'text':'Overall , tyrosine phosphorylation of proteins , phosphorylation of LAT and PLCgamma1 and gamma2 , and calcium influx were intact in RasGRP1 -/ - mast cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 14), 'text':'Calcium influx in mast cells is dependent on LAT , SLP-76 , and PLCgamma .'}, {'start':(4, 0), 'end':(4, 14), 'text':'LAT or SLP76 deficiency causes a marked decrease of PLCgamma phosphorylation and calcium flux .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 14), 'text':'RasGRP proteins are activated after binding to DAG , a product of PLCgamma hydrolysis .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 5), 'text':'Thus , it was not surprising'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 6), 'end':(6, 12), 'text':'that RasGRP1 deficiency did not affect FcepsilonRI'}, {'start':(6, 13), 'end':(6, 19), 'text':'mediated proximal signaling and calcium mobilization .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 24), 'text':'Although PI3K lipid products are important for optimal recruitment and activation of PLCgamma1 ( ) , as well as Tec family kinases ( ) ,'}, {'start':(7, 25), 'end':(7, 36), 'text':'their importance in FcepsilonRI mediated calcium mobilization is not entirely clear .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 16), 'text':'Mast cells deficient in Gab2 or Fyn , two critical molecules in FcepsilonRI mediated PI3K activation ,'}, {'start':(8, 17), 'end':(8, 23), 'text':'only have slightly reduced calcium flux .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 2), 'text':'It is possible'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(9, 3), 'end':(9, 7), 'text':'that in mast cells ,'}, {'start':(9, 8), 'end':(9, 28), 'text':'FcepsilonRI mediated PLCgamma activation and calcium mobilization are mainly dependent on recruitment of PLCgamma to the plasma membrane by LAT .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 9), 'text':'Normal PLCgamma phosphorylation and calcium mobilization in RasGRP1 -/ -'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 10), 'end':(10, 12), 'text':'mast cells suggested'}, {'start':(10, 13), 'end':(10, 22), 'text':'that DAG production is likely normal in these cells .'}]}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 14), 'text':'Defective PI3K activation and mast cell function were less likely due to failed DAG production'}, {'start':(11, 15), 'end':(11, 31), 'text':'because PMA induced activation of Akt , PKCdelta , and PDK1 was still diminished ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 18), 'text':'RasGRP1 deficiency affects Ras-Erk activation in the TCR signaling pathway ( ) , but not in the FcepsilonRI pathway'}, {'start':(12, 19), 'end':(12, 24), 'text':'based on our data here .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 7), 'text':'Normal activation of Erk in RasGRP1 -/ -'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 8), 'end':(13, 10), 'text':'mast cells suggested'}, {'start':(13, 11), 'end':(13, 28), 'text':'that Sos or other RasGRP family members might play a major role in FcepsilonRI mediated Ras-Erk activation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 3), 'text':'Even though we showed'}, {'start':(14, 4), 'end':(14, 10), 'text':'that RasGRP1 was expressed in BMMCs ,'}]}, {'start':(14, 11), 'end':(14, 21), 'text':'its abundance was not as high as in T cells .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 8), 'text':'RasGRP4 is a new member of the RasGRP family'}, {'start':(15, 9), 'end':(15, 16), 'text':'and is highly expressed in mast cells .'}]}]}, {'start':(16, 0), 'end':(16, 15), 'text':'C3H and HeJ mice express a unique isoform of RasGRP4 due to an aberrant splicing .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 6), 'text':'This aberrant splicing produces a dysfunctional protein'}, {'start':(17, 7), 'end':(17, 17), 'text':'that lacks a DAG binding domain ( C1 domain ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 12), 'text':'These mice are hyporesponsive to methacholine stimulation via the airway ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 13), 'end':(18, 13), 'text':'suggesting'}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(18, 14), 'end':(18, 25), 'text':'that RasGRP4 may have an important role in mast cell function ,'}, {'start':(18, 26), 'end':(18, 38), 'text':'although other genes in these mice can also contribute to the hyporesponsiveness .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 1), 'text':'We speculate'}, {'start':(19, 2), 'end':(19, 20), 'text':'that RasGRP4 might play a similar role in mast cells as RasGRP1 in T cells in Ras-Erk activation .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 3), 'text':'It is also possible'}, {'start':(20, 4), 'end':(20, 15), 'text':'that FcepsilonRI mediated Erk activation might be independent of RasGRP proteins .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 12), 'text':'In mast cells , Shc is phosphorylated upon FcepsilonRI engagement ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 10), 'text':'Through binding to the phosphorylated FcepsilonRI beta and gamma chains ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(22, 11), 'end':(22, 22), 'text':'Shc might recruit the Grb2 and Sos complex to the plasma membrane'}, {'start':(22, 23), 'end':(22, 27), 'text':'to initiate Ras-MAPK activation .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(23, 0), 'end':(23, 3), 'text':'Published studies have indicated'}, {'start':(23, 4), 'end':(23, 12), 'text':'that PI3K is important in mast cell function .'}]}]}]}]}, {'start':(24, 0), 'end':(24, 14), 'text':'Gene inactivation or pharmacological inhibition of PI3K impairs FcepsilonRI mediated degranulation and cytokine release .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(25, 0), 'end':(25, 16), 'text':'Recruitment of the p85 subunit of PI3K by Gab2 is required for its activation ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(26, 0), 'end':(26, 3), 'text':'However , the mechanism'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(26, 4), 'end':(26, 4), 'text':'underlying'}, {'start':(26, 5), 'end':(26, 23), 'text':'how PI3K is directly activated after its localization to membrane has not been clearly characterized in mast cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 2), 'text':'Our data suggested'}, {'start':(27, 3), 'end':(27, 26), 'text':'that full activation of PI3K after FcepsilonRI engagement requires not only membrane recruitment of p85 by Gab2 , but also activation by RasGRP1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 2), 'text':'Our results indicated'}, {'start':(28, 3), 'end':(28, 13), 'text':'that RasGRP1 is likely involved in PI3K activation through N-Ras .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 13), 'text':'The constitutively active form of N-Ras could rescue defective Akt activation and degranulation .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 13), 'text':'GTP bound Ras has been shown to interact with the p110 subunit of PI3K'}, {'start':(30, 14), 'end':(30, 18), 'text':'and induce its activation .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 7), 'text':'Efficient PI3K activation in platelet derived growth factor'}, {'start':(31, 8), 'end':(31, 17), 'text':'induced signaling requires the function of Ras ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 13), 'text':'Because RasGRP1 deficiency did not affect Gab2 phosphorylation and the recruitment of p85 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 14), 'end':(32, 21), 'text':'it is likely that RasGRP1 activates N-Ras ,'}, {'start':(32, 22), 'end':(32, 37), 'text':'which further induces PI3K activation through its interaction with p110 in FcepsilonRI signaling ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 19), 'text':'It is not clear why RasGRP1 is only involved in the activation of N-Ras , not K-Ras or H-Ras .'}, {'start':(34, 0), 'end':(34, 24), 'text':'Despite the structural similarities among these Ras proteins , their differential posttranslational modifications target them to different microdomains at the membrane or subcellular compartments .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 2), 'text':'Recent studies suggest'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(35, 3), 'end':(35, 3), 'text':'that'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(35, 4), 'end':(35, 8), 'text':'upon T cell activation ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(35, 9), 'end':(35, 14), 'text':'RasGRP1 translocates to the Golgi apparatus'}, {'start':(35, 15), 'end':(35, 20), 'text':'to activate Ras ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'Subsequent studies show'}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 3), 'end':(36, 15), 'text':'that N-Ras is activated upon engagement of the TCR and PLCgamma1 activation ,'}, {'start':(36, 16), 'end':(36, 26), 'text':'and RasGRP1 may activate N-Ras in the Golgi ( ) .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(37, 0), 'end':(37, 4), 'text':'It remains to be determined'}, {'start':(37, 5), 'end':(37, 22), 'text':'whether activation of N-Ras by RasGRP1 in mast cells occurs in the Golgi or the plasma membrane .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 24), 'text':'In contrast with its role in FcepsilonRI mediated signaling , RasGRP1 is not essential for PI3K and Erk activation in IL-3 or SCF signaling .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 5), 'text':'IL-3 initiates the Jak-Stat pathway ,'}, {'start':(39, 6), 'end':(39, 14), 'text':'whereas SCF activates the c-Kit receptor tyrosine kinase .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 21), 'text':'Upon phosphorylation , the IL-3 receptor and c-Kit bind to the Shc-Grb2-Sos complex directly to activate the Ras-MAPK pathway and to p85'}, {'start':(40, 22), 'end':(40, 27), 'text':'to activate the PI3K pathway .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 21), 'text':'Why RasGRP1 is required for the FcepsilonRI pathway , but not the IL-3- or SCF mediated pathway , is not clear .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(42, 0), 'end':(42, 2), 'text':'It is possible'}, {'start':(42, 3), 'end':(42, 14), 'text':'that IL-3- or SCF mediated PI3K activation does not require Ras .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 10), 'text':'To investigate why RasGRP1 -/ - cells failed to degranulate ,'}, {'start':(43, 11), 'end':(43, 20), 'text':'we analyzed FcepsilonRI mediated granule translocation and cytoskeletal rearrangement .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 2), 'text':'Our data indicated'}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 3), 'end':(44, 12), 'text':'that granules failed to translocate to the plasma membrane ,'}, {'start':(44, 13), 'end':(44, 28), 'text':'and the formation of microtubules was defective in RasGRP1 -/ - cells after FcepsilonRI engagement .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 2), 'text':'F-actin rearrangement ,'}, {'start':(45, 3), 'end':(45, 16), 'text':'which is regulated by Ca 2+ and Ca 2+ -dependent PKCs ( ) ,'}]}, {'start':(45, 17), 'end':(45, 24), 'text':'was normal in RasGRP1 -/ - cells .'}]}, {'start':(46, 0), 'end':(46, 13), 'text':'This result was expected because Ca 2+ flux was normal in these cells .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(47, 0), 'end':(47, 2), 'text':'Our data showed'}, {'start':(47, 3), 'end':(47, 13), 'text':'that RhoA activation was defective in RasGRP1 -/ - cells .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 7), 'text':'Vav proteins are GEFs for Rho family GTPases'}, {'start':(48, 8), 'end':(48, 9), 'text':'( )'}]}, {'start':(48, 10), 'end':(48, 23), 'text':'and can be regulated by the substrates and products of PI3K ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 13), 'text':'Different members of the Vav family ( Vav1 , Vav2 , and Vav3 )'}, {'start':(49, 14), 'end':(49, 33), 'text':'may have different specificities toward different Rho GTPases , such as Cdc42 , Rac1 , and RhoA ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 3), 'text':'It is not clear'}, {'start':(50, 4), 'end':(50, 11), 'text':'which GEF specifically activates Rac1 and RhoA .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 11), 'text':'In RasGRP1 -/ - cells , Rac1 activation was relatively normal ,'}, {'start':(51, 12), 'end':(51, 17), 'text':'whereas RhoA activation was reduced .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 9), 'text':'It is possible that RasGRP1 activates the PI3K pathway ,'}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(52, 10), 'end':(52, 19), 'text':'which in turns activates a specific GEF for RhoA ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 20), 'end':(52, 26), 'text':'although we can not exclude the possibility'}, {'start':(52, 27), 'end':(52, 41), 'text':'that RasGRP1 is also an exchange factor for RhoA in the FcepsilonRI signaling pathway .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 14), 'text':'Lyn and Fyn activate two independent pathways upon engagement of the FcepsilonRI ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 12), 'text':'Activation of the Lyn-Syk-LAT pathway leads to calcium flux and MAPK activation ,'}, {'start':(54, 13), 'end':(54, 27), 'text':'whereas the Fyn-Gab2-PI3K pathway is responsible for AKT , PKCdelta activation , and degranulation .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(55, 0), 'end':(55, 3), 'text':'It has been proposed'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 4), 'end':(55, 13), 'text':'that there might be cross talks between these two pathways'}, {'start':(55, 14), 'end':(55, 22), 'text':'to synergize cytokine production and degranulation ( ) .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(56, 0), 'end':(56, 2), 'text':'Our data suggested'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 3), 'end':(56, 15), 'text':'that RasGRP1 might link LAT phosphorylation and PLCgamma activation to PI3K activation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(56, 16), 'end':(56, 20), 'text':'thereby connecting the Lyn initiated'}, {'start':(56, 21), 'end':(56, 32), 'text':'pathway to the Fyn initiated pathway in mast cells ( ) .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(57, 0), 'end':(57, 5), 'text':'In summary , our results indicated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 6), 'end':(57, 13), 'text':'that RasGRP1 is an essential regulator of FcepsilonRI'}, {'start':(57, 14), 'end':(57, 17), 'text':'mediated allergic responses .'}]}]}]}]}]}]}
